Article
Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma…
Journal of Ophthalmology · 2017 · Ashraf Bor’i, author Ashraf Mahrous, author Mahmoud A. Al-Aswad, author Haitham Y. Al-Nashar, author Waled M. Nada, author Mostafa Wagih, author Ahmed M. B. Awad, author Wael M. El-Haig, author Enrico Peiretti, Academic Editor
Key facts
| Title | Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study |
|---|---|
| First author | Ashraf Bor’i, author Ashraf Mahrous, author Mahmoud A. Al-Aswad, author Haitham Y. Al-Nashar, author Waled M. Nada, author Mostafa Wagih, author Ahmed M. B. Awad, author Wael M. El-Haig, author Enrico Peiretti, Academic Editor |
| Journal | Journal of Ophthalmology |
| Published | Aug 18, 2017 |
| DOI | 10.1155/2018/4160837 |
| Devices mentioned | K101223, K113129, K121993, K152205, K172649, K173648, K181594, K182569, K192391, K201252, K223557, K240221 and 1 more |
| Product codes mentioned | HOO, OBO, MYC, MXK, HPT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1